Surgery Partners, Inc.
SGRY
$23.19
$0.020.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.23% | 12.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.23% | 12.20% | |||
| Cost of Revenue | -2.65% | 6.39% | |||
| Gross Profit | -30.69% | 31.61% | |||
| SG&A Expenses | 0.00% | 23.29% | |||
| Depreciation & Amortization | 7.08% | -32.47% | |||
| Other Operating Expenses | -- | -322.73% | |||
| Total Operating Expenses | -0.72% | 3.18% | |||
| Operating Income | -48.21% | 72.48% | |||
| Income Before Tax | -100.40% | 580.73% | |||
| Income Tax Expenses | -- | 2,584.44% | |||
| Earnings from Continuing Operations | 99.36% | -828.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 39.58% | -62.47% | |||
| Net Income | 65.25% | -242.27% | |||
| EBIT | -48.21% | 72.48% | |||
| EBITDA | -39.15% | 37.48% | |||
| EPS Basic | 65.36% | -242.24% | |||
| Normalized Basic EPS | -194.71% | 618.15% | |||
| EPS Diluted | 65.10% | -242.24% | |||
| Normalized Diluted EPS | -194.71% | 618.15% | |||
| Average Basic Shares Outstanding | 0.31% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.31% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||